142 related articles for article (PubMed ID: 22966250)
1. Molecular prognostic factors in rectal cancer treated by preoperative chemoradiotherapy.
Nam TK; Lee JS; Kim HR; Ahn SJ; Song JY; Yoon MS
Oncol Lett; 2010 Jan; 1(1):23-29. PubMed ID: 22966250
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
Kim J; Ahn S; Kim K; Cho MS; Kim KH; Lee RA; Nam EM
Anticancer Res; 2018 Dec; 38(12):6881-6889. PubMed ID: 30504405
[TBL] [Abstract][Full Text] [Related]
3. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial.
Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R
Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of concurrent chemotherapy regimen on clinical outcomes of preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim E; Kim K; Oh H; Han SW; Kim TY; Jung SY; Park KJ; Kang GH; Chie EK
J BUON; 2019; 24(2):470-478. PubMed ID: 31127993
[TBL] [Abstract][Full Text] [Related]
6. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.
Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
8. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma.
Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS
Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639
[TBL] [Abstract][Full Text] [Related]
9. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
[TBL] [Abstract][Full Text] [Related]
10. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.
Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Inoue Y; Kobayashi M; Miki C; Kusunoki M
J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578
[TBL] [Abstract][Full Text] [Related]
11. Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Kamijo A; Akiba T; Kawada S
Int J Clin Oncol; 2015 Dec; 20(6):1130-9. PubMed ID: 25833701
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD).
Kılıç D; Sert F; Görken İB; Arıcan Alıcıkuş Z; Aktürk N; Kaytan Sağlam E; Kizir A; Özkök S; Yılmaz HT; Göçen F; Yalman D
Turk J Gastroenterol; 2020 May; 31(5):368-377. PubMed ID: 32519956
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
Sung S; Son SH; Park EY; Kay CS
PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
Huang WS; Kuan FC; Lin MH; Chen MF; Chen WC
Ann Surg Oncol; 2020 Oct; 27(11):4309-4318. PubMed ID: 32794029
[TBL] [Abstract][Full Text] [Related]
15. Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer.
Yoon WH; Kim HJ; Kim CH; Joo JK; Kim YJ; Kim HR
Ann Surg Treat Res; 2015 Jan; 88(1):15-20. PubMed ID: 25553320
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.
Hong YS; Kim SY; Lee JS; Nam BH; Kim KP; Kim JE; Park YS; Park JO; Baek JY; Kim TY; Lee KW; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
J Clin Oncol; 2019 Nov; 37(33):3111-3123. PubMed ID: 31593484
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
[TBL] [Abstract][Full Text] [Related]
19. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
[TBL] [Abstract][Full Text] [Related]
20. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]